Cardiometabolic Risk

James Matera, DO, on Managing Comorbid CVD, Diabetes, and Kidney Disease

04/22/2020

James Matera, DO, from CentraState Medical Center, explains why CVD, diabetes, and kidney disease often occur together, and how the presence of one or more of these conditions can complicate treatment outcomes. He also discusses how the 2017 ACC/AHA hypertension guideline has impacted disease management in this patient population.

For more, visit our Diabetes and Nephrology Resource Centers.

James J. Matera, DO, FACOI, is a nephrologist and Medical Director of Population Health at CentraState Medical Center in Freehold, New Jersey.

References:

1. de Boer IH, Sun W, Cleary PA, et al; DCCT/EDIC Research Group. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med. 2011;365:2366-2376. doi:10.1056/NEJMoa1111732.

2. Rosenstock J, Perkovic V, Johanssen OE, et al. Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: The CARMELINA Randomized Clinical Trial. JAMA. 2019;321(1):69-79. doi:10.1001/jama.2018.18269.

3. Das SR, Everett BM, Birtcher KK, et al. 2018 ACC expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease: A report of the American College of Cardiology Task Force on expert consensus decision pathways. J Am Coll Cardiol. 2018. doi:10.1016/j.jacc.2018.09.020.

4. Carey RM, Whelton PK; 2017 ACC/AHA Hypertension Guideline Writing Committee. Prevention, detection, evaluation, and management of high blood pressure in adults: Synopsis of the 2017 American College of Cardiology/American Heart Association hypertension guideline. Ann Intern Med. 2018;168(5):351-358. doi:10.7326/M17-3203.

Related Content

decision-making
decision-making
Claire Barber, MD, on Using Patient Aids for Rheumatoid Arthritis Care
05/19/2021
Dr Barber discusses the lessons learned from her research into the use of patient aids and shared decision making among patients with rheumatoid arthritis and their health care providers.
05/19/2021
Cardiovascular Diseases
Cardiovascular Diseases
Peter H. Jones, MD, on Treating Dyslipidemia: a Preview
11/03/2020
In this podcast, Peter Jones, MD, gives a preview of his presentation on the prevention of cardiovascular disease and the treatment of dyslipidemia, which will be presented at the Practical Updates in...
11/03/2020
Oncology
Oncology
Jaspal Singh, MD, on Evolving Diagnostic and Treatment Modalities for Lung Cancer
11/19/2018
Jaspal Singh, MD, discusses the evolving diagnostic and treatment modalities for lung cancer, with an emphasis on proper screening.
11/19/2018
Cardiovascular Diseases
Cardiovascular Diseases
Stephen Juraschek, MD, PhD, on OH Assessment, Dizziness in Older Adults
11/07/2019
The STURDY study recently evaluated how OH timing is associated with dizziness in older patients. Coauthor Stephen P. Juraschek, MD, PhD, discusses these findings and how they compare with past...
11/07/2019
Rheumatoid Arthritis
Rheumatoid Arthritis
Megan Clowse, MD, on Treating RA During Pregnancy
06/26/2019
Megan Clowse, MD, from Duke University, discusses treatments for rheumatoid arthritis that are safe during pregnancy, the importance of educating women early on about their options, and more. 
06/26/2019